Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Metastatic bulk to predict subclonal heterogeneity by ctDNA in RAS/RAF-wildtype colorectal cancer.
Authors
Jeremy D. Kratz
University of Wisconsin Carbone Cancer Center, Madison, WI
Jeremy D. Kratz , Sam Joseph Lubner , Noelle K. LoConte , Monica Arun Patel , Nataliya Volodymyrivna Uboha , Dyan M. Lesnik , Sara Ahmed , Michael J. Kelley , Kayla Lemmon , Michael Frederick Bassetti , Cristina Sanger , Dustin A. Deming
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.186
Abstract #
186
Poster Bd #
J7
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2021 ASCO Annual Meeting
Comprehensive molecular profiling of advanced cancers in a real-world setting using an ultrasensitive amplicon-based next-generation sequencing (NGS) liquid biopsy assay.
First Author: Jonathan Poh
Poster
2014 Gastrointestinal Cancers Symposium
Molecular profiling of patients (pts) with advanced colorectal cancer (CRC): Princess Margaret Cancer Centre experience.
First Author: Joanne W. Chiu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective observational study of monitoring gene alterations in plasma cell-free DNA using droplet digital PCR system during anti-EGFR antibody treatment in patients with RAS wild-type advanced colorectal cancer.
First Author: Naoki Takahashi
First Author: Sandra Algaze